HER-2/neu in node-negative breast cancer: Prognostic significance of overexpression influenced by the presence of in situ carcinoma

Journal of Clinical Oncology

Volumn 10, Issue 4, 1992, Pages 599-605

  Allred, D C ^a   Clark, G M ^a   Tandon, A K ^a   Molina, R ^a   Tormey, D C ^a   Osborne, C K ^a   Gilchrist, K W ^a   Mansour, E G ^a   Abeloff, M ^a   Eudey, L ^a   McGuire, W L ^a  

^a UNIVERSITY OF TEXAS AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; ESTROGEN RECEPTOR; FLUOROURACIL; METHOTREXATE; PREDNISOLONE;

ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER ADJUVANT THERAPY; CARCINOMA IN SITU; GENE ACTIVATION; GENE AMPLIFICATION; GENE EXPRESSION; HIGH RISK PATIENT; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; ONCOGENE; PRIORITY JOURNAL; PROGNOSIS; TUMOR VOLUME;

EID: 0026576399     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1992.10.4.599     Document Type: Article

References (0)